Pierr Johnson's Comments RSS Syndication from SeekingAlpha.com http://seekingalpha.comuser/276403/comments http://seekingalpha.com/article/174932/comments?source=feed#comment-775545 775545
The impact on the marketability of competing products to Cerezyme is unclear to me. Anecdotal evidence suggests many patients could adapt to the temporary shortage of both Cerezyme and Fabrazyme. But consensus estimates encompass a return to 20% annual growth. A stock that serially stumbles deserves its detractors. That said, if the company meets its established mileposts (at long last, indeed), the smarter money will be long at this point in time]]> Tue, 24 Nov 2009 14:07:20 -0500
The impact on the marketability of competing products to Cerezyme is unclear to me. Anecdotal evidence suggests many patients could adapt to the temporary shortage of both Cerezyme and Fabrazyme. But consensus estimates encompass a return to 20% annual growth. A stock that serially stumbles deserves its detractors. That said, if the company meets its established mileposts (at long last, indeed), the smarter money will be long at this point in time]]> http://seekingalpha.com/article/129778/comments?source=feed#comment-454821 454821
My advice to Sun management: It is time to slice and dice. In a normalized economy, technologies and businesses must not be supported with the expense structures of bygone eras. With regard to your products, show us (as Michael Capellas once said) what’s under the Kimono. Once these businesses are more profitably and clearly reflected in financial results, higher valuations will follow. Once non-core middling’s are gone (or at least disaggregated), investors will accord shares the appropriate valuation.

]]> Tue, 07 Apr 2009 10:48:47 -0400
My advice to Sun management: It is time to slice and dice. In a normalized economy, technologies and businesses must not be supported with the expense structures of bygone eras. With regard to your products, show us (as Michael Capellas once said) what’s under the Kimono. Once these businesses are more profitably and clearly reflected in financial results, higher valuations will follow. Once non-core middling’s are gone (or at least disaggregated), investors will accord shares the appropriate valuation.

]]> http://seekingalpha.com/article/99046/comments?source=feed#comment-277830 277830
Surely IRF was brought to its knees striving to seek the highest value in its franchise through serious accounting and business malfeasance. That said, the reporting mechanisms are back in place and a new management presides over a higher value Power IC and Discrete franchise that is intact. Even in its weakened state, this business model is inherently more profitable than that Vishay has so capably pursued over the years. It requires higher levels of investment and different channels that target different sorts of customers.

It is not clear to me why Vishay is expending such effort to pursue what seems clearly to be an ill-conceived business combination. Granted, IRF shares are severely depressed, and the accounting scandal has strained its business. Yet a cheap price alone hardly justifies this intervention in IRF's turn-around. And given its size and difficulty, it could very well gum up Vishay's execution as well. For now, I am on the side lines (and unable to vote).]]> Thu, 09 Oct 2008 12:38:13 -0400
Surely IRF was brought to its knees striving to seek the highest value in its franchise through serious accounting and business malfeasance. That said, the reporting mechanisms are back in place and a new management presides over a higher value Power IC and Discrete franchise that is intact. Even in its weakened state, this business model is inherently more profitable than that Vishay has so capably pursued over the years. It requires higher levels of investment and different channels that target different sorts of customers.

It is not clear to me why Vishay is expending such effort to pursue what seems clearly to be an ill-conceived business combination. Granted, IRF shares are severely depressed, and the accounting scandal has strained its business. Yet a cheap price alone hardly justifies this intervention in IRF's turn-around. And given its size and difficulty, it could very well gum up Vishay's execution as well. For now, I am on the side lines (and unable to vote).]]>